{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:49Z","timestamp":1792788289376,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82272658 and 81872451"],"award-info":[{"award-number":["82272658 and 81872451"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2022JDRC0042 and 2022NSFSC0777"],"award-info":[{"award-number":["2022JDRC0042 and 2022NSFSC0777"]}]},{"name":"CMC Excellent-talent Program","award":["2024kjTzn03"],"award-info":[{"award-number":["2024kjTzn03"]}]},{"name":"Organized Research Projects of Chengdu Medical College","award":["CYYZZ24-01"],"award-info":[{"award-number":["CYYZZ24-01"]}],"id":[{"id":"https:\/\/ror.org\/01c4jmp52","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Clinical Science Research Foundations of Collaborative Innovation Center of Sichuan for Elderly Care and Health","award":["2022LHTD-02"],"award-info":[{"award-number":["2022LHTD-02"]}]},{"name":"Sichuan Higher Education Institute Key Laboratory of Major Disease Target Discovery and Protein Drug Development","award":["23LHNBZZD07, 24LHBBYY1-08, 24LHBBYY1-09"],"award-info":[{"award-number":["23LHNBZZD07, 24LHBBYY1-08, 24LHBBYY1-09"]}]},{"name":"Development and Regeneration Key Lab of Sichuan Province","award":["24LHFYSZ1-27"],"award-info":[{"award-number":["24LHFYSZ1-27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03029-1","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:43:42Z","timestamp":1782726222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting AIF to trigger RIPKs\/MLKL necroptosis: a disulfiram-based strategy to reverse paclitaxel resistance in ovarian cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiaofeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-0400","authenticated-orcid":false,"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"3029_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3029_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4:1239\u201357.","journal-title":"Nat Cancer"},{"key":"3029_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"key":"3029_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101223","volume":"81","author":"GL Beretta","year":"2025","unstructured":"Beretta GL, Cassinelli G, Rossi G, Azzariti A, Corbeau I, Tosi D, et al. Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resist Updat. 2025;81:101223.","journal-title":"Drug Resist Updat"},{"key":"3029_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.719","volume":"5","author":"J Wu","year":"2020","unstructured":"Wu J, Wu Y, Zhao T, Wang X, Guo Q, Wang S, et al. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21-activated kinase 4. MedComm. 2020;5:e719.","journal-title":"MedComm"},{"key":"3029_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.semcancer.2022.03.028","volume":"86","author":"S Bose","year":"2022","unstructured":"Bose S, Saha P, Chatterjee B, Srivastava AK. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy. Semin Cancer Biol. 2022;86:568\u201379.","journal-title":"Semin Cancer Biol"},{"key":"3029_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01857-7","volume":"22","author":"B Wilczy\u0144ski","year":"2024","unstructured":"Wilczy\u0144ski B, D\u0105browska A, Kulbacka J, Baczy\u0144ska D. Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication. Cell Commun Signal. 2024;22:486.","journal-title":"Cell Commun Signal"},{"key":"3029_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH. Apoptosis in cancer biology and therapy. Annu Rev Pathol. 2025;20:303\u201328.","journal-title":"Annu Rev Pathol"},{"key":"3029_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3870","volume":"11","author":"H Zhang","year":"2025","unstructured":"Zhang H, Lv J, Wu H, He Y, Li M, Wu C, et al. Endogenous\/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy. Sci Adv. 2025;11:eadq3870.","journal-title":"Sci Adv"},{"key":"3029_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101226","volume":"81","author":"MZ Saleem","year":"2025","unstructured":"Saleem MZ, Huang R, Huang Y, Guo X, Liu Y, Gao M, et al. Targeting TRAP1-dependent metabolic reprogramming to overcome doxorubicin resistance in quiescent breast cancer. Drug Resist Updat. 2025;81:101226.","journal-title":"Drug Resist Updat"},{"key":"3029_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24:299\u2013315.","journal-title":"Nat Rev Cancer"},{"key":"3029_CR12","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.7150\/ijbs.72138","volume":"18","author":"S Jung","year":"2022","unstructured":"Jung S, Myagmarjav D, Jo T, Lee S, Han S, Quynh NTN, et al. Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation. Int J Biol Sci. 2022;18:3859\u201373.","journal-title":"Int J Biol Sci"},{"key":"3029_CR13","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.drup.2025.101229","volume":"81","author":"JR Wei","year":"2025","unstructured":"Wei JR, Lu MY, Wei TH, Fleishman JS, Yu H, Chen XL, et al. Overcoming cancer therapy resistance: From drug innovation to therapeutics. Drug Resist Updat. 2025;81:101229.","journal-title":"Drug Resist Updat"},{"key":"3029_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41392-025-02129-7","volume":"10","author":"R Nussinov","year":"2025","unstructured":"Nussinov R, Yavuz BR, Jang H. Molecular principles underlying aggressive cancers. Signal Transduct Target Ther. 2025;10:42.","journal-title":"Signal Transduct Target Ther"},{"key":"3029_CR15","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, et al. Lactylation in cancer progression and drug resistance. Drug Resist Updat. 2025;81:101248.","journal-title":"Drug Resist Updat"},{"key":"3029_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cytogfr.2025.06.008","volume":"84","author":"L Wang","year":"2025","unstructured":"Wang L, Cao Y, Wu Y, Li Y, Bai Y, Zhou Q, et al. Necroptosis in sepsis: Mechanisms and therapeutic potential. Cytokine Growth Factor Rev. 2025;84:74\u201386.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3029_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174.","journal-title":"J Hematol Oncol"},{"key":"3029_CR18","doi-asserted-by":"publisher","first-page":"133719","DOI":"10.1016\/j.jhazmat.2024.133719","volume":"467","author":"M Liu","year":"2024","unstructured":"Liu M, Lu J, Hu J, Chen Y, Deng X, Wang J, et al. Sodium sulfite triggered hepatic apoptosis, necroptosis, and pyroptosis by inducing mitochondrial damage in mice and AML-12 cells. J Hazard Mater. 2024;467:133719.","journal-title":"J Hazard Mater"},{"key":"3029_CR19","doi-asserted-by":"publisher","first-page":"189024","DOI":"10.1016\/j.bbcan.2023.189024","volume":"1878","author":"A Gielecinska","year":"2023","unstructured":"Gielecinska A, Kciuk M, Yahya EB, Ainane T, Mujwar S, Kontek R. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents? Biochim Biophys Acta Rev Cancer. 2023;1878:189024.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3029_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Inuzuka H, Wei W. Necroptosis pathways in tumorigenesis. Semin Cancer Biol. 2022;86:32\u201340.","journal-title":"Semin Cancer Biol"},{"key":"3029_CR21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hao F, Nan Y, Qu L, Na W, Jia C, et al. PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis. Int J Biol Sci. 2018;14:1883\u201391.","journal-title":"Int J Biol Sci"},{"key":"3029_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.","journal-title":"Signal Transduct Target Ther"},{"key":"3029_CR23","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Tang L, Chen Q, Wu L, He W, Tu D, et al. Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism. Nat Commun. 2022;13:6862.","journal-title":"Nat Commun"},{"key":"3029_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40265-021-01670-3","volume":"82","author":"EM Burnette","year":"2022","unstructured":"Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, et al. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs. 2022;82:251\u201374.","journal-title":"Drugs"},{"key":"3029_CR25","doi-asserted-by":"publisher","first-page":"121335","DOI":"10.1016\/j.biomaterials.2021.121335","volume":"281","author":"Y Lu","year":"2022","unstructured":"Lu Y, Pan Q, Gao W, Pu Y, Luo K, He B, et al. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens. Biomaterials. 2022;281:121335.","journal-title":"Biomaterials"},{"key":"3029_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41419-025-07672-3","volume":"16","author":"K Kudo","year":"2025","unstructured":"Kudo K, Greer YE, Crooks DR, Yang Y, Brender JR, Yoshida T, et al. Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer. Cell Death Dis. 2025;16:342.","journal-title":"Cell Death Dis"},{"key":"3029_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/CM9.0000000000002909","volume":"137","author":"M Zeng","year":"2024","unstructured":"Zeng M, Wu B, Wei W, Jiang Z, Li P, Quan Y, et al. Disulfiram: A novel repurposed drug for cancer therapy. Chin Med J (Engl). 2024;137:1389\u201398.","journal-title":"Chin Med J (Engl)"},{"key":"3029_CR28","doi-asserted-by":"publisher","first-page":"188357","DOI":"10.1016\/j.bbcan.2020.188357","volume":"1873","author":"R Mandal","year":"2020","unstructured":"Mandal R, Barr\u00f3n JC, Kostova I, Becker S, Strebhardt K. Caspase-8: The double-edged sword. Biochim Biophys Acta Rev Cancer. 2020;1873:188357.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3029_CR29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41418-022-00938-9","volume":"29","author":"X Li","year":"2022","unstructured":"Li X, Li F, Zhang X, Zhang H, Zhao Q, Li M, et al. Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3\/MLKL to prevent lymphopenia. Cell Death Differ. 2022;29:1500\u201312.","journal-title":"Cell Death Differ"},{"key":"3029_CR30","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/s41467-024-47271-y","volume":"15","author":"E Denisenko","year":"2024","unstructured":"Denisenko E, de Kock L, Tan A, Beasley AB, Beilin M, Jones ME, et al. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones. Nat Commun. 2024;15:2860.","journal-title":"Nat Commun"},{"key":"3029_CR31","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1016\/j.apsb.2023.02.021","volume":"13","author":"Q Pei","year":"2023","unstructured":"Pei Q, Jiang B, Hao D, Xie Z. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharm Sin B. 2023;13:3252\u201376.","journal-title":"Acta Pharm Sin B"},{"key":"3029_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M, et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat Rev Clin Oncol. 2023;20:820\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"3029_CR33","doi-asserted-by":"crossref","unstructured":"Miao D, Matulonis UA, Porter RL. Ovarian cancer therapy. Cold Spring HarbPerspect Med. 2026;16(3):a038232 .","DOI":"10.1101\/cshperspect.a038232"},{"key":"3029_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9:92.","journal-title":"Signal Transduct Target Ther"},{"key":"3029_CR35","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41591-024-03233-x","volume":"30","author":"K Huang","year":"2024","unstructured":"Huang K, Chandak P, Wang Q, Havaldar S, Vaid A, Leskovec J, et al. A foundation model for clinician-centered drug repurposing. Nat Med. 2024;30:3601\u201313.","journal-title":"Nat Med"},{"key":"3029_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7:286.","journal-title":"Signal Transduct Target Ther"},{"issue":"2025","key":"3029_CR37","first-page":"e70357","volume":"6","author":"Y Wei","year":"2020","unstructured":"Wei Y, Hankey W, Xu D, Yuan F. Programmed Cell Death in Cancer. MedComm. 2020;6(2025):e70357.","journal-title":"MedComm"},{"key":"3029_CR38","doi-asserted-by":"crossref","unstructured":"Martinez-Osorio V, Abdelwahab Y, Ros U. The many faces of MLKL, the executor of necroptosis.Int J Mol Sci. 2023;24(12):10108.","DOI":"10.3390\/ijms241210108"},{"key":"3029_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","volume":"84","author":"Y Ai","year":"2024","unstructured":"Ai Y, Meng Y, Yan B, Zhou Q, Wang X. The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell. 2024;84:170\u20139.","journal-title":"Mol Cell"},{"key":"3029_CR40","doi-asserted-by":"publisher","first-page":"1501659","DOI":"10.3389\/fimmu.2024.1501659","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Lin Y, Chen J, Luo X, Kan Y, He Y, et al. Targeting caspase-8: a new strategy for combating hepatocellular carcinoma. Front Immunol. 2024;15:1501659.","journal-title":"Front Immunol"},{"key":"3029_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-00406-w","volume":"8","author":"J Geng","year":"2017","unstructured":"Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun. 2017;8:359.","journal-title":"Nat Commun"},{"key":"3029_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/imm.13795","volume":"172","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou Y, Xi S, Han D, Wang Z, Zhu J, et al. The TRIF-RIPK1-Caspase-8 signalling in the regulation of TLR4-driven gene expression. Immunology. 2024;172:566\u201376.","journal-title":"Immunology"},{"key":"3029_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-025-07754-2","volume":"16","author":"BJ Kim","year":"2025","unstructured":"Kim BJ, Hong SM, Noh HJ, Kim J, Seon SY, Lee JE, et al. FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death. Cell Death Dis. 2025;16:426.","journal-title":"Cell Death Dis"},{"key":"3029_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12964-025-02272-2","volume":"23","author":"TNA Nguyen","year":"2025","unstructured":"Nguyen TNA, Lai HT, Fernandes R, Dall\u2019Olio FG, Bleriot C, Ha-Duong T, et al. Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases. Cell Commun Signal. 2025;23:264.","journal-title":"Cell Commun Signal"},{"key":"3029_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/iub.432","volume":"63","author":"L Delavallee","year":"2011","unstructured":"Delavallee L, Cabon L, Galan-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life. 2011;63:221\u201332.","journal-title":"IUBMB Life"},{"key":"3029_CR46","doi-asserted-by":"publisher","first-page":"e14397","DOI":"10.1111\/cns.14397","volume":"30","author":"Q Bai","year":"2024","unstructured":"Bai Q, Wang S, Rao D, Zhou Z, Wang J, Wang Q, et al. RIPK3 activation promotes DAXX-dependent neuronal necroptosis after intracerebral hemorrhage in mice. CNS Neurosci Ther. 2024;30:e14397.","journal-title":"CNS Neurosci Ther"},{"key":"3029_CR47","doi-asserted-by":"publisher","first-page":"e25301","DOI":"10.1002\/jnr.25301","volume":"102","author":"C Zhang","year":"2024","unstructured":"Zhang C, Liu R, Chen M, Xu Y, Jin X, Shen B, et al. Autophagy inhibitors 3-MA and BAF may attenuate hippocampal neuronal necroptosis after global cerebral ischemia-reperfusion injury in male rats by inhibiting the interaction of the RIP3\/AIF\/CypA complex. J Neurosci Res. 2024;102:e25301.","journal-title":"J Neurosci Res"},{"key":"3029_CR48","doi-asserted-by":"publisher","first-page":"14675","DOI":"10.1038\/s41598-022-19066-y","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Fan L, Wang X, Luo T, Liu L. Cyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis. Sci Rep. 2022;12:14675.","journal-title":"Sci Rep"},{"key":"3029_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41418-022-01061-5","volume":"30","author":"G Liccardi","year":"2023","unstructured":"Liccardi G, Annibaldi A. MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations. Cell Death Differ. 2023;30:269\u201378.","journal-title":"Cell Death Differ"},{"key":"3029_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11658-023-00434-z","volume":"28","author":"X Jiang","year":"2023","unstructured":"Jiang X, Li G, Zhu B, Zang J, Lan T, Jiang R, et al. p20BAP31 induces cell apoptosis via both AIF caspase-independent and the ROS\/JNK mitochondrial pathway in colorectal cancer. Cell Mol Biol Lett. 2023;28:25.","journal-title":"Cell Mol Biol Lett"},{"key":"3029_CR51","doi-asserted-by":"publisher","first-page":"103787","DOI":"10.1016\/j.redox.2025.103787","volume":"85","author":"T Liu","year":"2025","unstructured":"Liu T, Kong X, Qiao J, Wei J. Decoding Parkinson\u2019s Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations. Redox Biol. 2025;85:103787.","journal-title":"Redox Biol"},{"key":"3029_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2024.05.020","volume":"220","author":"H Wan","year":"2024","unstructured":"Wan H, Chen H, Liu J, Yang B, Zhang Y, Bai Y, et al. PARP1 inhibition prevents oxidative stress in age-related hearing loss via PAR-Ca(2+)-AIF axis in cochlear strial marginal cells. Free Radic Biol Med. 2024;220:222\u201335.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"3029_CR53","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.molcel.2023.12.041","volume":"84","author":"S Hou","year":"2024","unstructured":"Hou S, Zhang J, Jiang X, Yang Y, Shan B, Zhang M, et al. PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis. Mol Cell. 2024;84(5):938.","journal-title":"Mol Cell"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03029-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:25:28Z","timestamp":1789597528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3029"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03029-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were reviewed and approved by the Ethics Committee of Chengdu Medical College (No. 2023023).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the submission of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"492"}}